Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Rivas

Showing results (11-20 of 115) with videos related to

Pageof 12
Sort By:
Antimicrobial Agents and Chemotherapy|July 27, 2004
Role of positional hydrophobicity in the leishmanicidal activity of magainin 2Esther Guerrero, José María Saugar, Katsumi Matsuzaki, et al.
Frontiers in Immunology|June 6, 2018
Association of T and NK Cell Phenotype With the Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)Jose Luis Rivas, Teresa Palencia, Guerau Fernández, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2004
The dendritic cell receptor DC-SIGN discriminates among species and life cycle forms of LeishmaniaMaría Colmenares, Angel L Corbí, Salvatore J Turco, et al.
Journal of Medicinal Chemistry|February 5, 2010
New benzophenone-derived bisphosphonium salts as leishmanicidal leads targeting mitochondria through inhibition of respiratory complex IIJ Román Luque-Ortega, Peter Reuther, Luis Rivas, et al.
European Journal of Ophthalmology|March 28, 2018
Ocular surface changes in recurrent pterygium cases post-operatively treated with 5-fluorouracil subconjunctival injectionsAmanda García Tirado, Ana Boto de Los Bueis, Luis Rivas Jara
Molecular Pharmaceutics|August 19, 2010
The antitumoral depsipeptide IB-01212 kills Leishmania through an apoptosis-like process involving intracellular targetsJuan R Luque-Ortega, Luis J Cruz, Fernando Albericio, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 22, 2003
Solid-phase synthesis of the cyclic lipononadepsipeptide [N-Mst(Ser1), d-Ser4, L-Thr6, L-Asp8, L-Thr9]syringotoxinNuria Bayó, Jose C Jiménez, Luis Rivas, et al.
International Journal of Peptides|March 14, 2017
A Synthetic Strategy for Conjugation of Paromomycin to Cell-Penetrating Tat(48-60) for Delivery and Visualization into Leishmania ParasitesSira Defaus, Maria Gallo, María A Abengózar, et al.
Molecular Pharmaceutics|March 26, 2009
Kahalalide F, an antitumor depsipeptide in clinical trials, and its analogues as effective antileishmanial agentsLuis J Cruz, Juan R Luque-Ortega, Luis Rivas, et al.
Cornea|September 26, 2007
Histopathologic limbus evolution after alkaline burnsJosé Santiago López-García, Luis Rivas Jara, Isabel García-Lozano, et al.
Pageof 12

Showing results (11-20 of 115) with videos related to

Sort By:
Pageof 12
Antimicrobial Agents and Chemotherapy|July 27, 2004
Role of positional hydrophobicity in the leishmanicidal activity of magainin 2Esther Guerrero, José María Saugar, Katsumi Matsuzaki, et al.
Frontiers in Immunology|June 6, 2018
Association of T and NK Cell Phenotype With the Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)Jose Luis Rivas, Teresa Palencia, Guerau Fernández, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2004
The dendritic cell receptor DC-SIGN discriminates among species and life cycle forms of LeishmaniaMaría Colmenares, Angel L Corbí, Salvatore J Turco, et al.
Journal of Medicinal Chemistry|February 5, 2010
New benzophenone-derived bisphosphonium salts as leishmanicidal leads targeting mitochondria through inhibition of respiratory complex IIJ Román Luque-Ortega, Peter Reuther, Luis Rivas, et al.
European Journal of Ophthalmology|March 28, 2018
Ocular surface changes in recurrent pterygium cases post-operatively treated with 5-fluorouracil subconjunctival injectionsAmanda García Tirado, Ana Boto de Los Bueis, Luis Rivas Jara
Molecular Pharmaceutics|August 19, 2010
The antitumoral depsipeptide IB-01212 kills Leishmania through an apoptosis-like process involving intracellular targetsJuan R Luque-Ortega, Luis J Cruz, Fernando Albericio, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 22, 2003
Solid-phase synthesis of the cyclic lipononadepsipeptide [N-Mst(Ser1), d-Ser4, L-Thr6, L-Asp8, L-Thr9]syringotoxinNuria Bayó, Jose C Jiménez, Luis Rivas, et al.
International Journal of Peptides|March 14, 2017
A Synthetic Strategy for Conjugation of Paromomycin to Cell-Penetrating Tat(48-60) for Delivery and Visualization into Leishmania ParasitesSira Defaus, Maria Gallo, María A Abengózar, et al.
Molecular Pharmaceutics|March 26, 2009
Kahalalide F, an antitumor depsipeptide in clinical trials, and its analogues as effective antileishmanial agentsLuis J Cruz, Juan R Luque-Ortega, Luis Rivas, et al.
Cornea|September 26, 2007
Histopathologic limbus evolution after alkaline burnsJosé Santiago López-García, Luis Rivas Jara, Isabel García-Lozano, et al.
Pageof 12